ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)

ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)

<p><strong>Background</strong> This randomized phase 2 trial compared the efficacy and safety of second‐line nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel) with or without the addition of CC‐486 (an oral formulation of 5‐azacytidine) in patients with advanced‐stage, nonsqua...

書誌詳細
主要な著者:	Morgensztern, D, Cobo, M, Ponce Aix, S, Postmus, PE, Lewanski, CR, Bennouna, J, Fischer, JR, Juan-Vidal, O, Stewart, DJ, Fasola, G, Ardizzoni, A, Bhore, R, Wolfsteiner, M, Talbot, DC, Jin Ong, T, Govindan, R, On Behalf Of The Abound L Investigators
フォーマット:	Journal article
言語:	English
出版事項:	Wiley 2018

類似資料

ABOUND.2L+: nab-paclitaxel (nab-P) +/- CC-486 or durvalumab in previously treated patients with advanced non-small cell lung cancer (NSCLC)
著者:: Morgensztern, D, 等
出版事項: (2017)

Efficacy and safety of second- or third-line nab-paclitaxel + durvalumab in patients with advanced NSCLC (ABOUND.2L+)
著者:: Morgensztern, D, 等
出版事項: (2018)

Quality of life in patients with advanced NSCLC treated in second- or third-line with nab-paclitaxel + durvalumab: abound.2l+
著者:: Talbot, D, 等
出版事項: (2018)

Nab-paclitaxel + durvalumab as second- or third-line treatment of advanced NSCLC: results from ABOUND.2l+
著者:: Govindan, R, 等
出版事項: (2017)

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)
著者:: Daniel Morgensztern, 等
出版事項: (2021-02-01)

Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer
著者:: Ponce Aix, S, 等
出版事項: (2020)

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC
著者:: Corey J. Langer, 等
出版事項: (2018-07-01)

nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis
著者:: Corey J. Langer, 等
出版事項: (2021-01-01)

Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies.
著者:: Eric Laille, 等
出版事項: (2015-01-01)

nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2
著者:: Ajeet Gajra, 等
出版事項: (2018-07-01)

The uses of anxiety: Grace Abounding to the Chief of Sinners (1666)
著者:: Seymour, L
出版事項: (2023)

Short Toxin-like Proteins Abound in Cnidaria Genomes
著者:: Michal Linial, 等
出版事項: (2012-11-01)

Misperceptions of "light" cigarettes abound: National survey data
著者:: Thomson George, 等
出版事項: (2009-05-01)

Aboundance, Diversity and Distribution of Ichthyoplanktons in Creeks and Coastal Waters of Khouzestan Province
著者:: S. Dehghan; A. Savari; P. Kochenin; J. Ghafle marammazi
出版事項: (1999-01-01)

The Jurisdictional Basis, Elements and Remedies in the Action for Breach of Confidence - Uncertainty Abounds
著者:: Leo Tsaknis

Features of fibrosis regression abound in "non-cirrhotic" patients with resected hepatocellular carcinoma.
著者:: Christine E Orr, 等
出版事項: (2022-01-01)

Improbabilities abound”: Daphne du Maurier’s Rule Britannia and the speculative political future
著者:: Aoife Byrne
出版事項: (2015-07-01)

Features of fibrosis regression abound in “non-cirrhotic” patients with resected hepatocellular carcinoma
著者:: Christine E. Orr, 等
出版事項: (2022-01-01)

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
著者:: Véronique Hofman, MD, PhD, 等
出版事項: (2023-02-01)

Phase III, randomized, placebo-controlled trial of CC-486 (Oral Azacitidine) in patients with lower-risk myelodysplastic syndromes
著者:: Garcia-Manero, G, 等
出版事項: (2021)

An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
著者:: Neda Stjepanovic, 等
出版事項: (2020-10-01)

Exodus, Psalms and Hebrews: A God abounding in steadfast love (Ex 34:6)
著者:: Alphonso Groenewald
出版事項: (2008-03-01)

Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge
著者:: Jun Sugisaka, 等
出版事項: (2023-11-01)

Ticks and Tick-Borne Pathogens Abound in the Cattle Population of the Rabat-Sale Kenitra Region, Morocco
著者:: Latifa Elhachimi, 等
出版事項: (2021-12-01)

Soils rich in biological ice-nucleating particles abound in ice-nucleating macromolecules likely produced by fungi
著者:: F. Conen, 等
出版事項: (2018-07-01)

Length Frequency, Sex Ratio and Relative Aboundance (CPUE) of Astacus leptoductylus in Arass Reservior (1997-98)
著者:: M. Karimpor; N. Hosseinpor
出版事項: (1999-01-01)

Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial
著者:: Yoshimasa Shiraishi, 等
出版事項: (2022-09-01)

Computer processor unit 486
著者:: Universiti Teknologi Malaysia. Perpustakaan
出版事項: (1989)

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
著者:: Gridelli C, 等
出版事項: (2018-05-01)

Androgen Receptor Expression in Primary Nonsquamous Cell Rare-Variant Carcinomas of the Head and Neck
著者:: Siavash Rahimi MD, FRCPath, 等
出版事項: (2017-06-01)

Multicenter study of carbon‐ion radiation therapy for nonsquamous cell carcinomas of the oral cavity
著者:: Hiroaki Ikawa, 等
出版事項: (2019-09-01)

A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
著者:: Daichi Fujimoto, MD, 等
出版事項: (2022-02-01)

Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer
著者:: Hidetoshi Hayashi, 等
出版事項: (2011-01-01)

P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
著者:: Maria Amaya, 等
出版事項: (2023-08-01)

KIE 486 - KIMIA MAKANAN JUN 1994.
著者:: PPSK, Pusat Pengajian Sains Kimia
出版事項: (1994)

Brief Report: Impact of Maintenance Pemetrexed Cessation on Clinical Outcomes of Patients With Metastatic Nonsquamous NSCLC
著者:: Shreya Bhatia, BS, 等
出版事項: (2024-11-01)

Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021
著者:: Lisa M. Hess, PhD, 等
出版事項: (2022-06-01)

Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience
著者:: Laurent Greillier, 等
出版事項: (2016-10-01)

An Epidemiologic study of Oral and Pharyngeal Nonsquamous Cell Malignant Tumors inKerman province, Iran
著者:: MR. Zarei, 等
出版事項: (2007-03-01)

Glenn's Suzuki one-cylinder repair and tune-up guide : models 50 cc, 55 cc, 80 cc, 90 cc, 120 cc, 125 cc, 185 cc, 250 cc, 400 cc/
著者:: 402466 Crawford, Charles W., 等
出版事項: (1972)